Hugl-1 inhibits glioma cell growth in intracranial model

Journal of Neuro-oncology
Xuejiao LiuXiuping Zhou

Abstract

Drosophila lethal (2) giant larvae (lgl) has been reported as a tumor suppressor and could regulate the Drosophila hippo signaling. Human giant larvae-1(Hugl-1), one human homologue of Drosophila lgl, also has been reported to be involved in the development of some human cancers. However, whether Hugl-1 is associated with the pathogenesis of malignant gliomas remains poorly understood. In the present work, we examined the effect of Hugl-1 on glioma cell growth both in vitro and in vivo. Firstly, we found that Hugl-1 protein levels decreased in the human glioma tissues, suggesting that Hugl-1 is involved in glioma progression. Unfortunately, either stably or transiently over-expressing Hugl-1 did not affect glioma cell proliferation in vitro. In addition, Hugl-1 over-expression did not regulate hippo signaling pathway. Interestingly, over-expression of Hugl-1 not only inhibited gliomagenesis but also markedly inhibited cell proliferation and promoted the apoptosis of U251 cells in an orthotopic model of nude mice. Taken together, this study provides the evidence that Hugl-1 inhibits glioma cell growth in intracranial model of nude mice, suggesting that Hugl-1 might be a potential tumor target for glioma therapy.

References

Jun 8, 2001·Genes & Development·E A MaherR A DePinho
Dec 6, 2003·The Journal of Cell Biology·Melissa M RollsChris Q Doe
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nils Ole SchmidtRona S Carroll
Sep 20, 2005·Oncogene·S KuphalA K Bosserhoff
Mar 2, 2006·Developmental Neuroscience·Valeri Vasioukhin
Dec 14, 2007·Oncology Research·Tetsushi TsurugaYuji Taketani
Dec 25, 2007·Biochemical and Biophysical Research Communications·Tim ZimmermannDennis Strand
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
May 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xuefeng LuZhengjun Chen
Apr 7, 2010·Current Biology : CB·Nicola A GrzeschikHelena E Richardson
Oct 15, 2010·Journal of Cellular Physiology·Siew Wee ChanWanjin Hong
Oct 19, 2010·Developmental Cell·Duojia Pan
Dec 9, 2010·Development·Georg Halder, Randy L Johnson
Jul 9, 2011·Progress in Biophysics and Molecular Biology·Yangjin KimHans G Othmer
Aug 25, 2011·Nature Reviews. Cancer·Gemma K Alderton
Feb 18, 2012·The Journal of Biological Chemistry·Wesley M KonsavageGregory S Yochum
Mar 15, 2012·Cancer Research·Melody A SwartzYves A DeClerck
Apr 19, 2012·Lancet·Damien RicardJean-Yves Delattre
Oct 2, 2012·Biochemical and Biophysical Research Communications·Xiuping ZhouRutong Yu
Jul 19, 2013·World Journal of Gastroenterology : WJG·Jia SongWei-Guo Dong

❮ Previous
Next ❯

Citations

Feb 16, 2018·BioMed Research International·Simona PagliaDaniela Grifoni
Oct 1, 2017·Journal of Experimental & Clinical Cancer Research : CR·Yan WangXiuping Zhou
May 7, 2019·Canadian Journal of Gastroenterology & Hepatology·Alexander DesukiCarl C Schimanski
May 27, 2020·Journal of Cellular and Molecular Medicine·Xuejiao LiuRutong Yu
Aug 10, 2019·Biochemical and Biophysical Research Communications·Jun WangRutong Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis